Browse this journal

Latest articles

‘Latest articles’ are articles accepted for publication in this journal but not yet published in a volume/issue. Articles are removed from the ‘Latest articles’ list when they are published in a volume/issue. Latest articles are citable using the author(s), year of online publication, article title, journal and article DOI.

Download Citation Download PDFs

Review Article

Review Article
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di, Christopher T. Su, Andrew J. Cowan, Ajay K. Gopal & Rahul Banerjee
Published online: 15 May 2024
  • 42 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek, Wei-Ying Jen, Hagop M. Kantarjian, David McCue, Fadi G. Haddad, William Wierda, Alessandra Ferrajoli, Jan Burger, Tareq Abusab, Jeffrey Jorgensen, Sa A. Wang, Keyur Patel, Sanam Loghavi, Susan O’Brien & Farhad Ravandi
Published online: 15 May 2024
  • 20 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth, Jingjing Zhang, Timothy Miller, Joshua Menke, Jean Oak & Sebastian Fernandez-Pol
Published online: 15 May 2024
  • 4 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas, Maria Chaouki, Sandra de Barros, Baptiste Bonneau, Ben Allal, Julie Guillermet-Guibert & Loïc Ysebaert
Published online: 15 May 2024
  • 4 Views
  • 0 CrossRef citations
  • 0Altmetric

Correction

Correction
Correction
Published online: 14 May 2024
  • 11 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Letter to the Editor

Letter to the Editor
Treatment of methotrexate-refractory primary central nervous system lymphoma (PCNSL) at Memorial Sloan Kettering Cancer Center
Seena Cherian, Lisa Modelevsky, Anne S. Reiner & Christian Grommes
Published online: 14 May 2024
  • 9 Views
  • 0 CrossRef citations
  • 0Altmetric

Emerging Drug Profile

Emerging drug profile: JAK inhibitors
Alexander Coltoff & Andrew Kuykendall
Published online: 13 May 2024
  • 29 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
A de novo germline RUNX1 variant preceding development of concurrent T-lymphoblastic leukemia and myelodysplastic syndrome
Cassandra P. Wang, Juanita E. Ferreira, Alexander Placek, Paibel Aguayo-Hiraldo, Gordana Raca, Brent L. Wood, Karin P. Miller, Thomas Coates, David R. Freyer & Alexandra E. Kovach
Published online: 11 May 2024
  • 42 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study
Farhad Ravandi, Marion Subklewe, Roland B. Walter, Pankit Vachhani, Gert Ossenkoppele, Veit Buecklein, Hartmut Döhner, Mojca Jongen-Lavrencic, Claudia D. Baldus, Lars Fransecky, Timothy S. Pardee, Hagop Kantarjian, Priscilla K. Yen, Lata Mukundan, Bharat Panwar, Marc R. Yago, Suresh Agarwal, Sophia K. Khaldoyanidi & Anthony Stein
Published online: 07 May 2024
  • 95 Views
  • 0 CrossRef citations
  • 0Altmetric

Review Article

Review Article
Advances in the management of higher-risk myelodysplastic syndromes: future prospects
Georgina Gener-Ricos, Juan Jose Rodriguez-Sevilla, Samuel Urrutia, Alex Bataller, Alexandre Bazinet & Guillermo Garcia-Manero
Published online: 07 May 2024
  • 50 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide
Peter A. von dem Borne, Berit M. Kemps-Mols, Liesbeth C. de Wreede, Adriaan A. van Beek, Tjeerd J.F. Snijders, Daniëlle van Lammeren, Janneke Tijmensen, Aniko Sijs-Szabó, Mirjam A. Oudshoorn, Constantijn J.M Halkes, Peter van Balen, W.A. Erik Marijt, Jennifer M.L. Tjon, Joost S.P Vermaat & Hendrik Veelken
Published online: 06 May 2024
  • 176 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Article

Article
Risk factors for treatment-related bone loss and osteoporosis in patients with follicular lymphoma
Yong Xing, Kaifeng Ye, Chunyuan Li, Jinyao He, Fei Dong & Yun Tian
Published online: 06 May 2024
  • 154 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Article

Article
Real-world patterns and sequences of targeted therapy use in chronic lymphocytic leukemia and small lymphocytic lymphoma in the United States: a longitudinal study
Scott F. Huntington, Wendy Y. Cheng, Eric M. Sarpong, Siyang Leng, Mohammed Z. H. Farooqui, Uchechukwu Samuel Agu, Maryaline Catillon, Dominique Lejeune, Nathaniel Downes, Lisa Matay, Mei Sheng Duh & Enrico De Nigris
Published online: 02 May 2024
  • 301 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Article

Article
BRAF mutation in myeloid neoplasm: incidences and clinical outcomes
Tareq Abuasab, Shehab Mohamed, Naveen Pemmaraju, Tapan M. Kadia, Naval Daver, Courtney D. DiNardo, Farhad Ravandi, Wei Qiao, Guillermo Montalban-Bravo & Gautam Borthakur
Published online: 02 May 2024
  • 43 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Direct and indirect costs for patients with myeloproliferative neoplasms
Jingbo Yu, James Nelson, Taylor Marlin, Evan Braunstein & Michelle Jerry
Published online: 27 Apr 2024
  • 271 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review Article

Review Article
Targets and treatments in primary CNS lymphoma
Christina von Roemeling, Andrés J. M. Ferreri, Carole Soussain, Han W. Tun & Christian Grommes
Published online: 24 Apr 2024
  • 918 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Article

Article
Effect of tyrosine kinase inhibitors on male fertility in patients with chronic phase chronic myeloid leukemia
George Nesr, Simone Claudiani, Dragana Milojkovic, Andrew Innes, Fiona Fernando, Irene Caballes, Patience Mungozi, Richard Szydlo, Silvia Lovato, Channa Jayasena & Jane Apperley
Published online: 23 Apr 2024
  • 396 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review Article

Review Article
Challenges in management of older patients with chronic myeloid leukemia
Jessica M. Stempel, Rory M. Shallis, Rong Wong & Nikolai A. Podoltsev
Published online: 23 Apr 2024
  • 83 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Cost-effectiveness of adding quizartinib to induction chemotherapy for patients with FLT3-mutant acute myeloid leukemia
Jan Philipp Bewersdorf, Kishan K. Patel, Rory M. Shallis, Nikolai A. Podoltsev, Tariq Kewan, Jessica Stempel, Lourdes Mendez, Maximilian Stahl, Eytan M. Stein, Scott F. Huntington, George Goshua & Amer M. Zeidan
Published online: 22 Apr 2024
  • 97 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
A retrospective cohort study describing chemotherapy-induced peripheral neuropathy in Non-Hodgkin lymphoma patients treated with EPOCH ± R: does HIV status matter?
Gretchen A. McNally, Connor M. Aossey, Tracy Wiczer, Loraine T. Sinnott, Mark Lustberg, Robert A. Baiocchi & Maryam Lustberg
Published online: 22 Apr 2024
  • 395 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review Article

Review Article
Evaluating targeted therapies in older patients with TP53-mutated AML
Jean M.G. Sabile, Ronan Swords & Jeffrey W. Tyner
Published online: 22 Apr 2024
  • 126 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Evaluation of safety outcomes with transitioning obinutuzumab from standard rate to short duration infusion in patients with chronic lymphocytic leukemia
Caroline Fleck, Allison Karabinos, Allene Cook, Donald C. Moore & Ryan Jacobs
Published online: 22 Apr 2024
  • 40 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Light-chain-restricted Russell body oral mucositis: an immunohistochemical study and literature review
Luana Stefanie Silvino Gonçalves, Karina Helen Martins, Magdalena Raquel Torres Reyes, Isabella Silva Catananti, Fernando Chahud & Jorge Esquiche León
Published online: 18 Apr 2024
  • 88 Views
  • 0 CrossRef citations
  • 0Altmetric

Review Article

Review Article
Management of relapsed/refractory mantle cell lymphoma
Musa Alzahrani & Diego Villa
Published online: 18 Apr 2024
  • 132 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
High remission rates and transition to allogeneic transplant in older patients with newly diagnosed FLT-3 mutated acute myelogenous leukemia with midostaurin plus intensive chemotherapy
Jose Tinajero, Dat Ngo, Jianying Zhang, Ni-Chun Tsai, Ahmed Aribi, Ibrahim Aldoss, Vaibhav Agrawal, Shukaib Arslan, Idoroenyi Amanam, Hoda Pourhassan, Karamjeet Sandhu, Monzr Al-Malki, Vinod Pullarkat, Pamela Becker, Ryotaro Nakamura, Anthony Stein, Guido Marcucci, Andrew Artz, Paul Koller & Amandeep Salhotra
Published online: 18 Apr 2024
  • 44 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study
Ibrahim Aldoss, Jianying Zhang, Marjorie Robbins, Joo Song, Monzr M. Al Malki, Salman Otoukesh, Karamjeet Sandhu, Vaibhav Agrawal, Alex F. Herrera, Leslie L. Popplewell, Lucy Ghoda, Anthony Stein, Guido Marcucci, Stephen Forman & Vinod Pullarkat
Published online: 17 Apr 2024
  • 62 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
COVID-19 antibody titers after tixagevimab–cilgavimab injection in patients with hematologic diseases; a single-center, prospective study
Naokazu Nakamura, Hiroko Tsunemine, Ryo Ikunari, Tomomi Sakai & Nobuyoshi Arima
Published online: 16 Apr 2024
  • 27 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Prevalence of geriatric impairments and frailty categorization among real-world patients with multiple myeloma: a prospective cohort study (MFRAIL)
Imran Haider, Darryl P. Leong, Martha Louzada, Arleigh McCurdy, Gregory R. Pond, Ruthanne Cameron, Mohammed Aljama, Alissa Visram, Tanya M. Wildes & Hira Mian
Published online: 16 Apr 2024
  • 73 Views
  • 0 CrossRef citations
  • 0Altmetric

Review Article

Review Article
B cell receptor signaling proteins as biomarkers for progression of CLL requiring first-line therapy
Mischa Y. L. Vervoordeldonk, Paul J. Hengeveld, Mark-David Levin & Anton W. Langerak
Published online: 15 Apr 2024
  • 444 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Article

Article
The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes within the veterans health administration (VHA)
Andrew Ta, Supreet Kaur, Michael Mader, Kathleen Franklin, Madison Williams, Ryan Williams, Jean-Pierre Blaize, Amna Naqvi, Snegha Ananth, Michael Song, Brian Oliver Warnecke, Abhishek Pandya, Lakene Raissa Djoufack Djoumessi, Phillip Nazarewicz, Manuel Espinoza-Gutarra, Kana Tai Lucero, Jennifer Whitehead, Alaq Al-Abayechi, Lauren Boyle, Sophia Lee, Gabriel Roman Souza, Esteban Toro Velez, Ian Mines & Zohra Nooruddin
Published online: 15 Apr 2024
  • 73 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Two recurrent types of IGH::5′ BCL2 breakpoints representing cytogenetic ins(14;18)(q32;q21q21) and t(14;18)(q32;q21), mediated by the VDJ and class switch recombination processes, respectively
Fumiyo Maekawa, Masahiko Hayashida, Kayo Takeoka, Katsuhiro Fukutsuka, Miho Nakagawa, Takashi Akasaka, Shinichi Sakamoto, Shinji Sumiyoshi, Yoichiro Kobashi & Hitoshi Ohno
Published online: 12 Apr 2024
  • 74 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Successful treatment with cladribine in a patient with Rosai–Dorfman disease complicated by severe, prolonged marrow aplasia
Tadeusz Robak, Marcin Braun, Anna Guminska, Elżbieta Iskierka-Jażdżewska & Paweł Robak
Published online: 12 Apr 2024
  • 30 Views
  • 0 CrossRef citations
  • 0Altmetric

Review Article

Review Article
The mechanism of action, pharmacological characteristics, and clinical utility of the amyloid depleter birtamimab for the potential treatment of AL amyloidosis
Giovanni Palladini, Michaela Liedtke, Wagner Zago, Phil Dolan, Gene G. Kinney & Morie A. Gertz
Published online: 11 Apr 2024
  • 990 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Article

Article
Safety and efficacy of parsaclisib in combination with rituximab, bendamustine + rituximab, or ibrutinib in patients with previously treated B-cell lymphoma: analysis of a phase 1 dose-finding study (CITADEL‑112)
Juan-Manuel Sancho, Pau Abrisqueta, Abhijeet Kumar, Raul Cordoba, Monica Tani, Peter Langmuir, Erica Rappold, Teng Liu & Armando Lopez-Guillermo
Published online: 10 Apr 2024
  • 390 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review Article

Review Article
Bruton’s tyrosine kinase (BTK) inhibitors for the treatment of primary central nervous system lymphoma (PCNSL): current progress and latest advances
Lauren Schaff, Lakshmi Nayak & Christian Grommes
Published online: 10 Apr 2024
  • 914 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Review Article

Review Article
The prognostic significance of genomic complexity in patients with CLL
Ellinor Goergen & Othman Al-Sawaf
Published online: 09 Apr 2024
  • 89 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Normal and malignant cells are homogeneously distributed in the bone marrow of children
Sharon Veenbergen, Romana Jugooa, Jeroen te Marvelde, Andrica C.H de Vries & Vincent H. J. van der Velden
Published online: 08 Apr 2024
  • 22 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Gammopathic dermopathy: characterization of cutaneous MGUS
Emily R. Gordon, Caroline Chen, Megan H. Trager, Oluwaseyi Adeuyan, Brigit A. Lapolla, Lauren M. Fahmy, Celine M. Schreidah, David A. Wetter & Larisa J. Geskin
Published online: 06 Apr 2024
  • 90 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Hospital healthcare resource utilization and costs for chimeric antigen T-cell therapy and autologous hematopoietic cell transplant in patients with large B-cell lymphoma in the United States
Chendi Cui, Chaoling Feng, Ning Rosenthal, Sally W. Wade, Laura Curry, Christine Fu & Gunjan L. Shah
Published online: 03 Apr 2024
  • 517 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Letter to the Editor

Letter to the Editor
Successful treatment with bortezomib, thalidomide and dexamethasone in plasma cell myeloma post-bone marrow transplant
Yaqing Cao, Jingjing Shang, Yingying Zhai, Qingyuan Wang, Lingzhi Yan, Xiaolan Shi, Jing Wang, Ying Yao, Huifen Zhou, Aining Sun, Miao Miao, Chengcheng Fu & Song Jin
Published online: 01 Apr 2024
  • 57 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Olutasidenib in post-venetoclax patients with mutant isocitrate dehydrogenase 1 (mIDH1) acute myeloid leukemia (AML)
Jorge Cortes, Brian A. Jonas, Gary Schiller, Alice Mims, Gail J. Roboz, Andrew H. Wei, Pau Montesinos, P. Brent Ferrell, Karen WL. Yee, Pierre Fenaux, Anthony Schwarer & Justin M. Watts
Published online: 27 Mar 2024
  • 1358 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Letter to the Editor

Letter to the Editor
Immunohistochemistry-based detection of TP53 mutations in acute myeloid leukemia: a promising high sensitivity diagnostic approach
Andrew Matthews, Elena Fenu, Sarah J. Skuli, Jaryse C. Harris, Adam Bagg & Catherine Lai
Published online: 27 Mar 2024
  • 58 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Significant impact of antibiotic exposure on GI-GVHD, NRM, and GRFS following allogeneic HCT with non-myeloablative Flu-TBI conditioning
Lenneke F. J. van Groningen, Suzanne van Dorp, Manita E. J. Bremmers, Shahira Fazel, Mieke W. H. Roeven, Nicole M. A. Blijlevens & Walter J. F. M. van der Velden
Published online: 23 Mar 2024
  • 408 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Article

Article
Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-cell lymphoma
Yun Kyoung Ryu Tiger, Salvia Jain, Stefan K. Barta, Seda Tolu, Brian Estrella, Ahmed Sawas, Jennifer K. Lue, Mark M. Francescone, Barbara Pro & Jennifer E. Amengual
Published online: 22 Mar 2024
  • 84 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Progressive TP53 inactivation in an aggressive splenic diffuse red pulp small B-cell lymphoma
Maria-Myrsini Tzioni, Alexandra Clipson, Zi Chen, Francesco Cucco, Andrew Wotherspoon, Stefan Dojcinov & Ming-Qing Du
Published online: 22 Mar 2024
  • 32 Views
  • 0 CrossRef citations
  • 0Altmetric

Letter to the Editor

Letter to the Editor
Predictive value of early molecular response to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia
Aya M. Abdallah, Hanafy Hafez, Youssef Madney, Sonia Ahmed, Dina Yassin, Sherine Salem, Rodina Yousry, Hisham Abdel-Azim, Leslie Lehmann & Alaa Elhaddad
Published online: 21 Mar 2024
  • 45 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Treatment outcome, toxicity, and quality of life of patients with bronchus-associated lymphoid tissue lymphoma
Lin-Rui Gao, Xinyue Wang, Yunpeng Wu, Xiao-Li Feng, Wei Rao, Xin Liu, Yong-Wen Song, Hui Fang, Bo Chen, Jing Jin, Yue-Ping Liu, Hao Jing, Yuan Tang, Ning-Ning Lu, Ning Li, Wen-Wen Zhang, Yirui Zhai, Shu-Lian Wang, Shu-Nan Qi & Ye-Xiong Li
Published online: 20 Mar 2024
  • 69 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
RAD21 mutations in acute myeloid leukemia
Dorottya Laczko, Corey Poveda-Rogers, Andrew H. Matthews, Oraine Snaith, Selina Luger, Adam Bagg, Gabriel C. Caponetti, Jennifer J.D Morrissette & Guang Yang
Published online: 20 Mar 2024
  • 146 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Article

Article
Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trial
Vikas Gupta, Stephen Oh, Timothy Devos, Viviane Dubruille, John Catalano, Tim C. P. Somervaille, Uwe Platzbecker, Pilar Giraldo, Hiroshi Kosugi, Tomasz Sacha, Jiri Mayer, Arpad Illes, Catherine Ellis, Zhaohui Wang, Francisco J. Gonzalez Carreras, Bryan Strouse & Ruben Mesa
Published online: 19 Mar 2024
  • 1718 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Article

Article
Lymphoplasmacytic lymphoma and multiple myeloma coexisting in the same patient: a case series and literature review
Gilad Itchaki, Osnat Jarhovsky, Jorge J. Castillo, Hamza Hassan, Moshe L. Gatt, Merav Leiba, Pia Raanani, Morie A. Gertz & Iuliana Vaxman
Published online: 19 Mar 2024
  • 59 Views
  • 0 CrossRef citations
  • 0Altmetric
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days